Remedium Lifecare Ltd
BSE:539561
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Remedium Lifecare Ltd
Net Income
Remedium Lifecare Ltd
Net Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
R
|
Remedium Lifecare Ltd
BSE:539561
|
Net Income
₹36.6m
|
CAGR 3-Years
34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Net Income
₹75.3B
|
CAGR 3-Years
20%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Net Income
₹70.4B
|
CAGR 3-Years
25%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Net Income
₹140.7B
|
CAGR 3-Years
40%
|
CAGR 5-Years
53%
|
CAGR 10-Years
N/A
|
|
|
Lupin Ltd
NSE:LUPIN
|
Net Income
₹53.9B
|
CAGR 3-Years
164%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Net Income
₹28.9B
|
CAGR 3-Years
32%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
Remedium Lifecare Ltd
Glance View
Remedium Lifecare Ltd is a IN-based company operating in Pharmaceuticals industry. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2016-01-12. Remedium Lifecare Limited is an India-based pharmaceutical company. The firm is aligned across two business verticals: Products and Services. The Products business comprises trading and sale of active pharmaceutical ingredients (APIs) and intermediates to innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets. The company is engaged in the business of trading in advanced pharmaceutical intermediates, API's and other pharma products used, such as iso propyl alcohol, cyclohexane, di iso propyl amine, ethyl acetate, hydrazine hydrate, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride, sodium carbonate (soda ash), amino isophthalic acid, tellurium(IV) oxide, Grignard reagent, selenium metal powder and trimethyl sulfoxonium iodide (TMSI). The company is involved with the manufacture of various APIs, such as atorvastatin calcium (Amorphous) and citalopram hydrochloride.
See Also
What is Remedium Lifecare Ltd's Net Income?
Net Income
36.6m
INR
Based on the financial report for Mar 31, 2025, Remedium Lifecare Ltd's Net Income amounts to 36.6m INR.
What is Remedium Lifecare Ltd's Net Income growth rate?
Net Income CAGR 3Y
34%
Over the last year, the Net Income growth was -93%. The average annual Net Income growth rates for Remedium Lifecare Ltd have been 34% over the past three years .